Research
Research & development.
The evidence base behind regenerative practice.
Research
The Institute advances regenerative medicine through ongoing scientific studies and multidisciplinary collaboration.
At LRI, our Research & Development (R&D) division is dedicated to advancing regenerative medicine and longevity science. Through cutting-edge research, we aim to develop innovative treatments and therapies that push the boundaries of healthcare, ensuring better outcomes.
Current methods like viral vectors have risks such as cytotoxicity and off-target effects. Investigating exosomes (small vesicles) as safer carriers capable of penetrating biological barriers, including the blood-brain barrier. Enhancing exosomes to carry larger molecules, like Cas9 plasmids, by creating hybrid exosomes with liposomes. Could revolutionize gene manipulation in human cells by improving the delivery of CRISPR/Cas9.
Exo-Filler is a groundbreaking project aimed at overcoming the limitations of traditional fillers used in aesthetic medicine and dermatology. By purifying biological materials derived from plasma, we produce biocompatible fillers with tailored firmness levels.
Our ongoing project explores the role of bioelectricity in modulating cellular senescence and promoting regeneration. Cellular senescence contributes to tissue dysfunction and inflammation. We are investigating how bioelectric signals can influence cellular behavior and tissue homeostasis to enhance regenerative processes.